June 9, 2020
Apple COVID screener now updates the CDC. A COVID-19 screening tool first released by Apple in late March can now report users' symptoms, location, health background and other health characteristics to the CDC. The goal is to help the public health agency aggregate more incidence and case data, which can be used to better inform the public about the disease and its risk factors.
These data are...
March 16, 2020
Alphabet's Verily has launched a website where California residents can complete a short survey regarding their current condition and, if they meet certain criteria, could be referred to a nearby mobile COVID-19 testing site.
Conducted through Verily's Project Baseline population health effort and developed in collaboration with federal, state and local public health authorities, the triage...
May 21, 2019
This morning Verily announced a series of new strategic partnerships with four global pharmaceutical companies that will bring low-burden digital data collection and analysis tools to clinical research projects.
Alongside Novartis, Otsuka, Pfizer and Sanofi, the Alphabet subsidiary will employ its Project Baseline platform to increase the number and diversity of study populations by making it...
May 19, 2017
The days of claiming artificial intelligence as a feature that set one startup or company apart from the others are over. These days, one would be hard-pressed to find any technology company attracting venture funding or partnerships that doesn’t posit to use some form of machine learning. But for companies trying to innovate in healthcare using artificial intelligence, the stakes are...
April 20, 2017
Alphabet-owned Verily has launched the Project Baseline Study, a collaborative effort with Stanford Medicine and Duke University School of Medicine to amass a large collection of broad phenotypic health data in hopes of developing a well-defined reference of human health.
Project Baseline aims to gather data from around 10,000 participants, each of whom will be followed for four years, and will...